Sector Highlight: Biotechnology ETFs

August 26th at 7:30am by Tom Lydon

  • Bookmark and Share

Biotechnology exchange traded funds (ETFs) are moving higher this morning after speculation that GlaxoSmithKline (GSK) could make an offer to take over Human Genome Sciences (HGSI). Here are more stories on the subject that may interest you:

Tickers

Subscribe to the ETF Trends Newsletter
Daily ETF News in your inbox
 
Your Email: 

Leave a Reply

You must be logged in to post a comment.